TWIST1 and hepatocellular carcinoma: Guo et al. [28] demonstrated that miR-33a-5p was lowly expressed in hepatocellular carcinoma cells, and overexpression of it could obviously inhibit the EMT process and cell invasion ability via binding to Twist1.